Renova Therapeutics | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Renova Therapeutics

BRIEF

published on 06/12/2024 at 15:05, 6 months 9 days ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
BRIEF

published on 06/12/2024 at 15:05, 6 months 9 days ago

Renova Therapeutics annonce l'expansion potentielle de sa plateforme de thérapie génique pour l'insuffisance cardiaque, le diabète et les affections associées

Essais Cliniques Thérapie Génique Rénova Thérapeutique Diabète Insuffisance Cardiaque
PRESS RELEASE

published on 06/12/2024 at 15:00, 6 months 9 days ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics announces exploration of new therapeutic opportunities expanding gene therapy use for diabetes and heart failure. Clinical trials and preclinical studies show promising results

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
BRIEF

published on 05/09/2024 at 03:05, 7 months 12 days ago

Renova Therapeutics Prioritizes Gene Therapy Development for Heart Failure and Type 2 Diabetes

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Treatment Type 2 Diabetes Treatment
BRIEF

published on 05/09/2024 at 03:05, 7 months 12 days ago

Renova Therapeutics donne la priorité au développement de thérapies géniques pour l'insuffisance cardiaque et le diabète de type 2

Essais Cliniques Thérapie Génique Rénova Thérapeutique Traitement De L'insuffisance Cardiaque Traitement Du Diabète De Type 2
PRESS RELEASE

published on 05/09/2024 at 03:00, 7 months 12 days ago

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics prioritizes two primary regulatory pathways for launching pivotal human trials of gene therapies to treat heart failure and type 2 diabetes mellitus

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Type 2 Diabetes Mellitus

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 47 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 47 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 12 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 17 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 47 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 25 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 31 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 6 hours 59 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 59 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE